Projects funded by the NCN

Information on the principal investigator and host institution

Information of the project and the call

Keywords

Equipment

Delete all

New strategies in the pharmacotherapy of neuropathic pain based on modulation of the chemokine system and its influence on opioid tolerance development

2021/43/B/NZ7/00230

Keywords:

neuropathic pain chemokines neuroimmunology microglia astroglia opioid analgesic drugs

Descriptors:

  • NZ7_014:

Panel:

NZ7 - Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology

Host institution :

Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

woj. małopolskie

Other projects carried out by the institution 

Principal investigator (from the host institution):

prof. Joanna Gabriela Mika 

Number of co-investigators in the project: 6

Call: OPUS 22 - announced on 2021-09-15

Amount awarded: 1 923 624 PLN

Project start date (Y-m-d): 2022-07-15

Project end date (Y-m-d): 2026-07-14

Project duration:: 48 months (the same as in the proposal)

Project status: Pending project

Project description

Download the project description in a pdf file

Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.

Information in the final report

  • Publication in academic press/journals (11)
  1. Analgesic effects of fisetin, peimine, astaxanthin, artemisinin, bardoxolone methyl and 740 Y-P and their influence on opioid analgesia in a mouse model of neuropathic pain
    Authors:
    Ciapała K, Rojewska E, Pawlik K, Ciechanowska A, Mika J
    Academic press:
    Int J. Mol Sci. (rok: 2023, tom: 24, strony: 45677), Wydawca: MDPI
    Status:
    Published
    DOI:
    10.3390/ijms24109000 - link to the publication
  2. New insights into the analgesic properties of the XCL1/XCR1 and XCL1/ITGA9 axes modulation under neuropathic pain conditions - evidence from animal studies
    Authors:
    Ciechanowska A, Rojewska E, Piotrowska A, Barut J, Pawlik K, Ciapała K, Kreiner G, Mika J.
    Academic press:
    Front Immunol. (rok: 2022, tom: 13, strony: 45678), Wydawca: Frontiers
    Status:
    Published
    DOI:
    10.3389/fimmu.2022.1058204 - link to the publication
  3. Mirogabalin decreases pain-like behaviors by inhibiting the microglial/macrophage activation, p38MAPK signaling, and pronociceptive CCL2 and CCL5 release in a mouse model of neuropathic pain
    Authors:
    Zajączkowska R, Pawlik K, Ciapała K, Piotrowska A, Ciechanowska A, Rojewska E, Kocot-Kępska M, Makuch W, Wordliczek J, Mika J
    Academic press:
    Pharmaceuticals (rok: 2023, tom: 16, strony: 45670), Wydawca: MDPI
    Status:
    Published
    DOI:
    10.3390/ph16071023 - link to the publication
  4. Mirogabalin decreases pain-like behaviors by inhibiting the microglial/macrophage activation, p38MAPK signaling, and pronociceptive CCL2 and CCL5 release in a mouse model of neuropathic pain
    Authors:
    Zajączkowska R, Pawlik K, Ciapała K, Piotrowska A, Ciechanowska A, Rojewska E, Kocot-Kępska M, Makuch W, Wordliczek J, Mika J
    Academic press:
    Pharmaceuticals (rok: 2023, tom: 16, strony: 45670), Wydawca: MDPI
    Status:
    Published
    DOI:
    10.3390/ph16071023 - link to the publication
  5. Analgesic effects of fisetin, peimine, astaxanthin, artemisinin, bardoxolone methyl and 740 Y-P and their influence on opioid analgesia in a mouse model of neuropathic pain
    Authors:
    Ciapała K, Rojewska E, Pawlik K, Ciechanowska A, Mika J
    Academic press:
    Int J. Mol Sci. (rok: 2023, tom: 24, strony: 45677), Wydawca: MDPI
    Status:
    Published
    DOI:
    10.3390/ijms24109000 - link to the publication
  6. CC Chemokine Receptor 4 (CCR4) as a Possible New Target for Therapy.
    Authors:
    Bogacka J, Pawlik K, Ciapała K, Ciechanowska A, Mika J.
    Academic press:
    Int J Mol Sci (rok: 2022, tom: 23, strony: 45677), Wydawca: MDPI
    Status:
    Published
    DOI:
    10.3390/ijms232415638 - link to the publication
  7. Targeting members of the chemokine family as a novel approach to treating neuropathic pain.
    Authors:
    Pawlik K, Mika J
    Academic press:
    Molecules (rok: 2023, tom: 28, strony: 15707), Wydawca: MDPI
    Status:
    Published
    DOI:
    10.3390/molecules28155766 - link to the publication
  8. Advances in neuropathic pain research: selected intracellular factors as potential targets for multidirectional analgesics.
    Authors:
    Ciapała K, Mika J.
    Academic press:
    Pharmaceuticals (rok: 2023, tom: 16, strony: 45681), Wydawca: MDPI
    Status:
    Published
    DOI:
    10.3390/ph16111624 - link to the publication
  9. Pharmacological evidence of the important roles of CCR1 and CCR3 and their endogenous ligands CCL2/7/8 in hypersensitivity based on a murine model of neuropathic pain
    Authors:
    Pawlik K, Ciapała K, Ciechanowska A, Kwiatkowski K, Mika J.
    Academic press:
    Cells (rok: 2023, tom: 12, strony: 45685), Wydawca: MDPI
    Status:
    Published
    DOI:
    10.3390/cells12010098 - link to the publication
  10. Pharmacological modulation of the MIP-1 family and their receptors reduces neuropathic pain symptoms and influences morphine analgesia: evidence from a mouse model
    Authors:
    Ciechanowska A, Pawlik K, Ciapała K, Mika J.
    Academic press:
    Brain Sci. (rok: 2023, tom: 13, strony: 45681), Wydawca: MDPI
    Status:
    Published
    DOI:
    10.3390/brainsci13040579 - link to the publication
  11. Phenytoin decreases pain-like behaviors and improves opioid analgesia in a rat model of neuropathic pain
    Authors:
    Kocot-Kępska M, Pawlik K, Ciapała K, Makuch W, Zajączkowska R, Dobrogowski J, Przeklasa-Muszyńska A, Mika J.
    Academic press:
    Brain Sci. (rok: 2023, tom: 13, strony: 45673), Wydawca: MDPI
    Status:
    Published
    DOI:
    10.3390/brainsci13060858 - link to the publication

O Narodowym Centrum Nauki

Finansowanie nauki

Współpraca zagraniczna

Centrum prasowe

Deklaracja dostępności
Przetwarzanie danych osobowych
Polityka cookies

Partnerzy